Status:

TERMINATED

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant

Lead Sponsor:

Bausch & Lomb Incorporated

Conditions:

Non-infectious Uveitis

Eligibility:

All Genders

6+ years

Phase:

PHASE2

PHASE3

Brief Summary

This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide intravitreal implants for the management of subjects with non-infectio...

Eligibility Criteria

Inclusion

  • Males or non-pregnant females at least 6 years of age who had been diagnosed and treated for recurrent,
  • Non-infectious uveitis affecting the posterior segment of one or both eyes for at least 1 year prior to the start of the study,
  • Had clinically 'quiet' eyes at surgery.

Exclusion

  • Coexistent medical or ocular conditions that would interfere with obtaining or interpreting data for this study.

Key Trial Info

Start Date :

May 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2006

Estimated Enrollment :

239 Patients enrolled

Trial Details

Trial ID

NCT00456482

Start Date

May 1 2002

End Date

April 1 2006

Last Update

December 8 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant | DecenTrialz